Lantheus Holdings, Inc.

Valuation Analysis

About the Company

Lantheus Holdings, Inc. en bref

Lantheus Holdings, Inc. (LNTH) is currently trading at 90,54 € with a market capitalization of 5,9 Md €. The trailing P/E ratio stands at 24.79x, with a forward P/E of 16.24x. The 52-week range spans from 41,19 € to 94,14 €; the current price is 3.8% below the yearly high. Year-over-year revenue growth stands at +1.2%. The net profit margin stands at 18.05%.

💰 Dividende

Lantheus Holdings, Inc. currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Avis des analystes

13 analystes évaluent Lantheus Holdings, Inc. (LNTH) au consensus : Achat Fort. L'objectif de cours moyen est de 91,74 €, soit un potentiel de +1.32% par rapport au cours actuel. La fourchette des objectifs de cours des analystes va de 66,25 € à 102,00 €.

Lantheus Holdings, Inc. : la thèse d'investissement en détail

Lantheus Holdings, Inc. (LNTH) operates in the Healthcare — specifically Drug Manufacturers - Specialty & Generic — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

Le scénario haussier

Earnings growth of 76.5% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. With a gross margin near 60.48%, the company sits in the top tier of its industry — these are the kinds of structural margins that protect earnings during downturns. Free cash flow is positive and net margins stand at 18.05%, meaning reported earnings translate into real cash that can fund buybacks, dividends or strategic acquisitions.

Le scénario baissier

Revenue growth has slowed to just 1.2%, which is below nominal GDP — the business is no longer outgrowing the broader economy. Short interest sits at 11.2% of float — a meaningful contingent of professionals is positioned for the share to fall, which deserves attention even if their thesis may turn out to be wrong.

À surveiller

• The forward P/E of 16.24x is meaningfully below the trailing 24.79x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 93.2% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Thèse d'investissement : forces et faiblesses

Aperçu technique

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Profil de risque

The data points to elevated short interest (11.2%).

Trading Data

Related Stocks in the Same Sector

Where can I buy Lantheus Holdings, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.